// IP Marketing video - START// IP Marketing video - END

U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
Armenia Aircompany will conduct regular flights to Germany and France starting from April 2018, Robert Hovhannisyan said.
Armenia is one of Fodor’s Go List of destinations which the magazine compiled as a reminder to hold strong to your enthusiasm for exploration.
Armenia was among the 10 most popular travel searches among the residents of the United Arab Emirates, Google revealed.
The pint-sized metropolis of the country, Yerevan punches far above its weight in terms of arty offerings, author Neeta Lal says.
Partner news